Loading…
Based on limited metadata, TaperAid received an FDA Warning Letter on January 11, 2018, regarding a product classified as "Other," though the specific product category and detailed violation information are not available in the metadata provided. Without access to the full letter text or subject line details, the precise nature of the regulatory concerns cannot be determined. The warning was issued by the FDA, though the specific issuing office is not identified in the available information. To understand the specific violations and required corrective actions, the complete Warning Letter would need to be reviewed.